We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

147 hedge funds and large institutions have $658M invested in Cytokinetics in 2020 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 59 increasing their positions, 39 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

51% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 39

50% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 16

13% more capital invested

Capital invested by funds: $584M → $658M (+$73.8M)

4% more funds holding

Funds holding: 142 → 147 (+5)

5% more call options, than puts

Call options by funds: $11.7M | Put options by funds: $11.2M

0.61% more ownership

Funds ownership: 93.13% → 93.75% (+0.61%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
147
Holders Change
+5
Holders Change %
+3.52%
% of All Funds
3.24%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
24
Increased
59
Reduced
39
Closed
16
Calls
$11.7M
Puts
$11.2M
Net Calls
+$535K
Net Calls Change
+$924K

Top Buyers

1
CCM
Consonance Capital Management
New York
+$43.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$14.7M
3
Citadel Advisors
Citadel Advisors
Florida
+$14.3M
4
FCM
Farallon Capital Management
California
+$7.97M
5
GPP
Great Point Partners
Connecticut
+$6.43M

Top Sellers

1
BI
BVF Inc
California
-$41.7M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$28.5M
3
Millennium Management
Millennium Management
New York
-$13.8M
4
BlackRock
BlackRock
New York
-$5.56M
5
Morgan Stanley
Morgan Stanley
New York
-$5.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$108M -$5.56M -435,411 -5%
Vanguard Group
2
Vanguard Group
Pennsylvania
$55.7M +$2.29M +179,746 +4%
BI
3
BVF Inc
California
$46.4M -$41.7M -3,268,178 -45%
CCM
4
Consonance Capital Management
New York
$40.5M +$43.8M +3,432,232 New
WA
5
Wasatch Advisors
Utah
$35.4M +$5.19M +406,453 +16%
DCM
6
Driehaus Capital Management
Illinois
$35.1M -$838K -65,654 -2%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$34.6M +$14.7M +1,149,373 +64%
State Street
8
State Street
Massachusetts
$31.7M +$1.86M +145,796 +6%
FCMI
9
Foresite Capital Management IV
California
$25.7M -$2.83M -221,678 -9%
Millennium Management
10
Millennium Management
New York
$17.6M -$13.8M -1,080,630 -42%
Citadel Advisors
11
Citadel Advisors
Florida
$13.7M +$14.3M +1,121,024 +2,566%
Morgan Stanley
12
Morgan Stanley
New York
$11.3M -$5.17M -404,873 -30%
RM
13
RP Management
New York
$10.3M – – –
Geode Capital Management
14
Geode Capital Management
Massachusetts
$10.1M +$737K +57,784 +7%
Point72 Asset Management
15
Point72 Asset Management
Connecticut
$9.33M -$28.5M -2,237,551 -74%
Northern Trust
16
Northern Trust
Illinois
$9.12M +$101K +7,900 +1%
Jacobs Levy Equity Management
17
Jacobs Levy Equity Management
New Jersey
$8.24M +$2.39M +187,022 +37%
Two Sigma Advisers
18
Two Sigma Advisers
New York
$7.94M +$1.95M +153,000 +29%
GPP
19
Great Point Partners
Connecticut
$7.83M +$6.43M +504,024 +315%
FCM
20
Farallon Capital Management
California
$7.37M +$7.97M +625,000 New
Bank of New York Mellon
21
Bank of New York Mellon
New York
$7.28M -$287K -22,475 -4%
Jennison Associates
22
Jennison Associates
New York
$7.24M +$53.5K +4,190 +0.7%
Goldman Sachs
23
Goldman Sachs
New York
$5.69M +$1.98M +155,047 +47%
Principal Financial Group
24
Principal Financial Group
Iowa
$5.39M -$230K -18,007 -4%
PA
25
Pinnacle Associates
New York
$4.75M -$913K -71,583 -15%
1
2 3 4 5

CYTK Hedge Fund Activity: Q1 2020 in Review

147 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q1 2020, worth a combined $658M — up 13% from $584M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new CYTK positions and 16 closed out — a net gain of 8 holders — while 59 added to existing stakes and 39 trimmed.

The largest buyer was Consonance Capital Management, opening a new position worth an estimated $43.8M. The largest seller was BVF Inc, cutting an estimated $41.7M.

  • 147 institutional investors held Cytokinetics (CYTK) as of Q1 2020, up from 142 in Q4 2019.
  • Funds reported $658M of Cytokinetics stock for Q1 2020, up 13% quarter-over-quarter.
  • 24 funds opened new Cytokinetics positions in Q1 2020 and 16 closed out, a net change of +8 holders.
  • The largest Cytokinetics buyer in Q1 2020 was Consonance Capital Management, an estimated $43.8M added.
  • The largest Cytokinetics seller in Q1 2020 was BVF Inc, an estimated $41.7M sold.

Based on aggregated 13F filings for Q1 2020.